Regulatory ApprovalHeartBeam's proprietary system for arrhythmia assessment received 510(k) clearance from the FDA, enhancing its credibility and market potential.
Strategic PartnershipsA strategic collaboration was signed with AccurKardia to add AccurECG algorithm to HeartBeam’s device, facilitating quicker diagnosis and faster access to clinical care.
Technology AdvancementHeartBeam's recent clearance for its at-home, high-fidelity heart monitoring technology is foundational and sets the table for further advancements.